This study provides initial characterization of brain MOR availability at high temporal resolution following intranasal (IN) naloxone administration to healthy volunteers in the absence of a competing opioid agonist.
Section: Naloxone Narcan
Topic:
Medication for Opioid Use Disorder (MOUD)
Naloxone/Narcan
Withdrawl/Withdrawl Management
Naloxone/Narcan
Withdrawl/Withdrawl Management
Setting:
Community-Based
Outpatient
Outpatient
Type: Literature Review